Preface -- 1 Role of bone marrow-derived CCR1+ cells in colon cancer invasion and metastasis.- 2 PGE2-associated inflammation and gastrointestinal tumorigenesis -- 3 Regulation of tumor-associated myeloid cells by innate immune signaling -- 4 The role of PIKfyve in TLR-mediated inflammation and immune responses -- 5 Emerging roles of an innate immune regulator TAPE in the Toll-like receptor and RIG-I-like receptor pathways -- 6 Anchorage-dependent multicellular aggregate formation induces CD44 high cancer stem cell-like phenotypes in adult T-cell leukemia/lymphoma cells -- 7 Tumor-associated molecular patterns: its implication in tumoricidal inflammation -- 8 Host factors involved in the propagation and pathogenesis of hepatitis C virus.- 9 HCV-induced inflammation: The role of cross-talk between HCV-infected hepatocytes and stellate cells -- 10 Development of immunotherapy for hepatocellular carcinoma -- 11 Development of glypican-3-targeted cancer immunotherapy -- 12 The vesicular traffic system in plasmacytoid dendritic cells as a target for immune regulation -- 13 In vivo targeting of dendritic cells with artificial adjuvant vector cells (aAVC) as a novel cancer immunotherapy -- 14 Enhancement of efficacy of WT1 peptide cancer vaccine by co-administration with immunopotentiating agents: Lessons from mouse models -- 15 Regulation of antigen-presentation by dendritic cells and its application to cancer immunotherapy -- 16 A new mode of CTL induction secondary to alteration of pMHCI repertoire by antigen processing defects -- 17 Progress in clinical use of CCR4 antibody for regulatory T cell suppression -- 18 Adjuvant Immunotherapy for cancer: Basic research to clinical bench -- 19 Immunological regulation of human cancer stem cell/cancer-initiating cells (CSC/CIC) -- 20 Overview on tumor immunology.-BM Epilogue.